2023-03-28 17:36:11 GAU Galiano Gold
03/28/23 03/2817:36 03/28/2317:36 | Galiano Gold reports Q4 EPS (3c), two estimates 1cReports Q4 cash provided by operating activities in Q4 2022 was $800K, compared to cash utilized in operations of $2.3M in Q4 2021. The increase in cash provided by operations was primarily due to collection of the Company's JV service fee which amounted to $2.4M in Q4 2022. As at December 31 the Company had cash and cash equivalents of $56.1M and $1.7M in receivables, while remaining debt-free. 2023 AGM Outlook. The Company reported net income after tax of $28.5M in Q4 2022, compared to a net loss after tax of $91M in Q4 2021. The increase in earnings during Q4 2022 was due to the recognition of the Company's share of the JV's net earnings for the yea and a $7.6M impairment reversal recorded by the Company on its equity investment in the AGM JV, which were partly offset by a $22.2Mdownward fair value adjustment on the Company's preference shares in the JV. In Q4, the Company recognized its share of the JV's net loss, which included a $153.2 million impairment charge. |
---|
Periodicals
|
Twitter loses another senior executive in charge of content, safety, WSJ says »
17:46 06/03/23 06/0317:46 06/03/2317:46
TWTR
A second senior executive… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announces updated data from Phase 2 TRiMM-2 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen presents analysis of infections, parameters in Monumen-TAL1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announced results from Phase 1/2 MonumenTAL-1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune Group announces 3 trial-in-progress abstracts at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Additional Abstracts… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents data from Phase 1 trial of RP2 with nivolumab at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune Group (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents RP1 data from IGNYTE trial at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
| Healthcare Analysts hold… Story temporarily locked. |
Hot Stocks
|
Janssen announces results from Phase 1b RedirecTT-1 study »
17:18 06/03/23 06/0317:18 06/03/2317:18
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Evaxion's trial of EVX-01 met its primary endpoints of safety, tolerability »
17:09 06/03/23 06/0317:09 06/03/2317:09
EVAX
Evaxion Biotech
Evaxion Biotech presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gracell presents long-term follow up data from study evaluating GC012F »
17:07 06/03/23 06/0317:07 06/03/2317:07
GRCL
Gracell
Gracell Biotechnologies… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Sutro Biopharma announces results from Phase 1 dose-expansion study of luvelta »
17:02 06/03/23 06/0317:02 06/03/2317:02
STRO
Sutro Biopharma
Sutro Biopharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Equitrans Midstream's Mountain Valley Pipeline to proceed »
16:58 06/03/23 06/0316:58 06/03/2316:58
ETRN
Equitrans Midstream
On June 3, 2023, the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cogent Biosciences announces data from ongoing Phase 3 PEAK trial »
16:56 06/03/23 06/0316:56 06/03/2316:56
COGT
Cogent Biosciences
Cogent Biosciences… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gilead, Arcus announce updated results from interim analysis of ARC-7 study »
16:53 06/03/23 06/0316:53 06/03/2316:53
GILD
Gilead
Arcus Biosciences
Gilead Science (GILD) and… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Alamo Group participates in a conference call with DA Davidson »
14:27 06/03/23 06/0314:27 06/03/2314:27
ALG
Alamo Group
Analyst Shlisky holds a… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Alamo Group management to meet virtually with DA Davidson »
14:04 06/03/23 06/0314:04 06/03/2314:04
ALG
Alamo Group
Analyst Shlisky holds a… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Peoples Bancorp management to meet virtually with DA Davidson »
13:59 06/03/23 06/0313:59 06/03/2313:59
PEBO
Peoples Bancorp
Analyst Navas holds a… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
NewAmsterdam's ROSE2 trial on obicetrapib met primary, secondary endpoints »
13:14 06/03/23 06/0313:14 06/03/2313:14
NAMS
NewAmsterdam
NewAmsterdam Pharma… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Precigen announces Phase 1 data of OTS PRGN-2009 AdenoVerse »
13:09 06/03/23 06/0313:09 06/03/2313:09
PGEN
Precigen
Precigen presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Elevation Oncology, CSPC announces initial clinical data for SYSA1801 »
13:02 06/03/23 06/0313:02 06/03/2313:02
ELEV
Elevation Oncology
CSPC
Elevation Oncology (ELEV)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Blueprint Medicines announces data from its VELA trial of BLU-222 »
12:59 06/03/23 06/0312:59 06/03/2312:59
BPMC
Blueprint Medicines
Blueprint Medicines… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Blueprint Medicines announces results from its EGFR Programs »
12:59 06/03/23 06/0312:59 06/03/2312:59
BPMC
Blueprint Medicines
Blueprint Medicines… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Merck announces results from Phase 3 KEYNOTE-671 trial evaluating KEYTRUDA »
12:50 06/03/23 06/0312:50 06/03/2312:50
MRK
Merck
Merck, known as MSD… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Allogene Therapeutics presents updated ALLO-501/501A Phase 1 data »
12:45 06/03/23 06/0312:45 06/03/2312:45
ALLO
Allogene Therapeutics
Allogene Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|